News | March 12, 2025
Nectar Lifesciences receives 7 observations from EDQM for API facility
The European regulator will conduct a re-inspection of the facility to verify the compliance
The European regulator will conduct a re-inspection of the facility to verify the compliance
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
This e-commerce platform is launched as a hyperlocal model
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
There are 38.4 million people with diabetes in the United States
USFDA inspection at Alembic Pharma's Bioequivalence facility
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Subscribe To Our Newsletter & Stay Updated
